3.25
price down icon4.97%   -0.17
after-market After Hours: 3.30 0.05 +1.54%
loading

Lantern Pharma Inc Stock (LTRN) Forecast

The Lantern Pharma Inc (LTRN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.4949, representing a +99.84% increase from the current price of $3.25. The highest analyst price target is $8.1971, and the lowest is $4.7928.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LTRN Price Target
Average 4.3065 (+32.51% Upside)
loading

Is Lantern Pharma Inc (LTRN) A Buy Now?

Oscillators
Name Value Action
RSI(14) 34.90 Neutral
STOCH(9,6) 14.69 Buy
STOCHRSI(14) 3.396 Buy
MACD(12,26) -0.1827 Sell
ADX(14) 22.84 Neutral
William %R -96.28 Buy
CCI(14) -203.88 Sell
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
3.601
Sell
3.5289
Sell
MA20
3.663
Sell
3.6777
Sell
MA50
4.1838
Sell
3.8759
Sell
MA100
3.844
Sell
3.9254
Sell
MA200
3.9061
Sell
4.1422
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, LTRN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on LTRN, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 34.9 indicates that LTRN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 14.69 indicates that LTRN is oversold. This indicates that LTRN price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.396 indicates that LTRN is oversold. This suggests that LTRN price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 22.84 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -203.88 indicates that LTRN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term LTRN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Lantern Pharma Inc financial reports and earnings history, Lantern Pharma Inc (LTRN) stock could reach $2.4931 by 2030, $19.25 by 2040 and $23.10 by 2050. See the projected annual prices until 2050 of the Lantern Pharma Inc stock below:

  • Lantern Pharma Inc (LTRN) is expected to reach an average price of $13.84 in 2035, with a high prediction of $14.25 and a low estimate of $14.06. This indicates an $325.86% rise from the last recorded price of $3.25.
  • Lantern Pharma Inc (LTRN) stock is projected to chart a bullish course in 2040, with an average price target of $17.99, representing an $453.63% surge from its current level. The forecast ranges from a conservative $19.00 to a sky-high $19.25.
  • Our analysts predict Lantern Pharma Inc (LTRN) to jump 536.48% by 2045, soaring from $21.02 to an average price of $20.69, potentially reaching $21.44. While $21.02 is the low estimate, the potential upside is significant.
  • Lantern Pharma Inc (LTRN) stock is expected to climb by 2050, reaching an average of $22.89, a $604.32% jump from its current level. However, a wide range of estimates exists, with high and low targets of $23.10 and $22.93, respectively, highlighting the market's uncertainty.

Lantern Pharma Inc Stock (LTRN) Year by Year Forecast

Lantern Pharma Inc Stock (LTRN) Price Forecast for 2025

Lantern Pharma Inc Stock (LTRN) is expected to reach an average price of $7.7357 in 2025, with a high prediction of $15.27 and a low estimate of $0.2001. This indicates an +138.02% rise from the last recorded price of $3.25.
Month Average Low High Change from today's price
May, 2025 $7.1742 $4.7928 $8.1971 +120.74%
June, 2025 $7.417 $6.1799 $8.6056 +128.22%
July, 2025 $6.0556 $4.6556 $7.6779 +86.33%
August, 2025 $3.8085 $2.6785 $7.1528 +17.18%
September, 2025 $5.9813 $3.7342 $7.2599 +84.04%
October, 2025 $3.5599 $1.6199 $5.972 +9.53%
November, 2025 $3.0327 $2.0313 $3.9056 -6.69%
December, 2025 $0.4813 $0.2001 $3.1884 -85.19%

Lantern Pharma Inc Stock (LTRN) Price Forecast for 2026

The predicted value for Lantern Pharma Inc (LTRN) in 2026 is set at an average of $0.8171. Estimates vary from a peak of $1.627 to a trough of $0.00728, indicating an -74.86% surge from the present price of $3.25.
Month Average Low High Change from today's price
January, 2026 $0.9341 $0.00728 $1.627 -71.26%
February, 2026 $0.623 $0.2644 $1.3056 -80.83%
March, 2026 $0.1602 $0.3259 $0.6241 -95.07%
April, 2026 $0.2484 $0.6316 $0.4187 -92.36%
May, 2026 $0.4013 $0.0602 $1.3113 -87.65%
June, 2026 $0.3559 $0.117 $0.6627 -89.05%
July, 2026 $0.6587 $0.793 $0.5046 -79.73%
August, 2026 $0.5645 $0.9624 $0.8759 -82.63%
September, 2026 $1.0159 $0.7831 $0.8112 -68.74%
October, 2026 $0.353 $0.4688 $0.6302 -89.14%
November, 2026 $0.9302 $0.9073 $0.6416 -71.38%
December, 2026 $1.1216 $1.1916 $0.8778 -65.49%

Lantern Pharma Inc Stock (LTRN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Lantern Pharma Inc (LTRN) is $0.705, with a high forecast of $1.3969 and a low forecast of $0.0132. This indicates an -78.31% decrease from the last price of $3.25.
Month Average Low High Change from today's price
January, 2027 $1.0188 $1.4923 $1.3502 -68.65%
February, 2027 $0.5059 $0.6574 $0.4509 -84.43%
March, 2027 $0.0726 $0.1024 $0.7226 -97.77%
April, 2027 $0.6455 $0.0745 $0.8155 -80.14%
May, 2027 $0.0717 $0.1974 $0.8569 -97.79%
June, 2027 $0.6281 $0.0903 $0.4397 -80.67%
July, 2027 $0.1603 $0.1903 $0.2124 -95.07%
August, 2027 $0.0626 $0.0769 $0.6769 -98.07%
September, 2027 $1.2011 $0.054 $1.3211 -63.04%
October, 2027 $0.244 $0.214 $1.3969 -92.49%
November, 2027 $0.2368 $0.0132 $0.4797 -92.71%
December, 2027 $0.1854 $0.0303 $1.2526 -94.29%

Lantern Pharma Inc Stock (LTRN) Price Forecast for 2028

In 2028, Lantern Pharma Inc (LTRN) is projected to reach an average price of $4.2136, with a high projection of $8.3896 and a low estimate of $0.0376. This indicates an +29.65% rise from the last price of $3.25.
Month Average Low High Change from today's price
January, 2028 $0.9617 $0.1889 $0.4192 -70.41%
February, 2028 $1.5889 $1.2703 $1.3089 -51.11%
March, 2028 $0.1083 $0.3203 $1.5032 -96.67%
April, 2028 $0.2625 $0.3552 $0.2725 -91.92%
May, 2028 $0.1311 $0.0376 $0.5915 -95.97%
June, 2028 $0.4239 $0.1168 $0.6681 -86.96%
July, 2028 $0.4468 $0.0954 $1.9111 -86.25%
August, 2028 $4.1854 $0.5226 $8.3896 +28.78%
September, 2028 $1.6282 $1.4183 $4.7211 -49.90%
October, 2028 $6.9171 $1.7639 $5.1271 +112.84%
November, 2028 $6.04 $5.7729 $5.8157 +85.85%
December, 2028 $1.5543 $6.1586 $6.3357 -52.17%

Lantern Pharma Inc Stock (LTRN) Price Forecast for 2029

The 2029 price forecast for Lantern Pharma Inc Stock (LTRN) is $3.7092 on average, with a high prediction of $7.1999 and a low estimate of $0.2184. This represents an +14.13% increase from the previous price of $3.25.
Month Average Low High Change from today's price
January, 2029 $1.4272 $1.4515 $1.5514 -56.09%
February, 2029 $2.4185 $0.6657 $4.1962 -25.58%
March, 2029 $1.1358 $1.2399 $7.1999 -65.05%
April, 2029 $1.4901 $1.6301 $1.0644 -54.15%
May, 2029 $2.127 $0.4508 $4.077 -34.55%
June, 2029 $1.7873 $1.6285 $4.0799 -45.01%
July, 2029 $1.1584 $0.2856 $2.7756 -64.36%
August, 2029 $1.7856 $0.5256 $7.0427 -45.06%
September, 2029 $0.4013 $0.2184 $4.6784 -87.65%
October, 2029 $0.7716 $1.4873 $1.053 -76.26%
November, 2029 $0.4259 $0.6888 $0.7112 -86.90%
December, 2029 $2.4802 $1.1345 $0.9872 -23.69%

Lantern Pharma Inc Stock (LTRN) Price Forecast for 2030

Lantern Pharma Inc Stock (LTRN) is expected to reach an average price of $4.4631 in 2030, with a high forecast of $7.306 and a low forecast of $1.6202. This signifies an +37.33% surge from the last price of $3.25.
Month Average Low High Change from today's price
January, 2030 $3.8031 $2.7745 $2.4931 +17.02%
February, 2030 $1.5274 $1.6202 $0.8616 -53.00%
March, 2030 $4.0517 $3.2059 $3.7117 +24.67%
April, 2030 $4.386 $4.596 $4.1774 +34.95%
May, 2030 $5.9088 $5.0031 $5.2488 +81.81%
June, 2030 $6.8331 $6.886 $6.5131 +110.25%
July, 2030 $7.566 $7.0817 $7.306 +132.80%
August, 2030 $7.0003 $7.1917 $7.1046 +115.39%
September, 2030 $6.6346 $7.4775 $7.2075 +104.14%
October, 2030 $6.2075 $6.0989 $6.3832 +91.00%
November, 2030 $6.8618 $6.4661 $6.6118 +111.13%
December, 2030 $7.0161 $7.1961 $6.9077 +115.88%
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Cap:     |  Volume (24h):